Edition:
India

Arrowhead Pharmaceuticals Files For Regulatory Clearance To Begin Phase 1 Study Of ARO-AAT


Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Arrowhead Pharmaceuticals Inc ::ARROWHEAD PHARMACEUTICALS FILES FOR REGULATORY CLEARANCE TO BEGIN PHASE 1 STUDY OF ARO-AAT.ARROWHEAD PHARMACEUTICALS INC - APPLICATION FOR APPROVAL OF CLINICAL TRIAL WAS SUBMITTED TO NEW ZEALAND MEDICINES AND MEDICAL DEVICES SAFETY AUTHORITY. 

Company Quote

37.44
0.84 +2.30%
8:44pm IST